Vaccine maker Serum seeks indemnity protection in India
India is currently witnessing a ferocious second wave of Covid-19. At the same time, an acute shortage of Covid vaccines has seriously hampered the country's mass inoculation drive
Serum's Covidshield is being widely used in both India and Bangladesh's mega inoculation drives. Bangladesh has inked a deal with Serum to buy 30 million doses of Covidshield, but a recent surge in Covid cases in India has now made the delivery of the remaining doses uncertain.
In a recent interview with a British daily, Serum's chief executive officer Adar Poonawalla said that the company would increase the vaccine production capacity from the existing 2.5 billion to 3 billion doses a year within six months.
India is currently witnessing a ferocious second wave of Covid-19. At the same time, an acute shortage of Covid vaccines has seriously hampered the country's mass inoculation drive.
Keep updated, follow The Business Standard's Google news channel
Prime Minister Modi rolled out the world's largest Covid vaccination drive on January 16. Covishield and local company Bharat Biotech's Covaxin are currently being given to citizens.
